Suppr超能文献

MATR3 P154S 敲入小鼠不表现肌萎缩侧索硬化症的运动、肌肉或神经病理学特征。

MATR3 P154S knock-in mice do not exhibit motor, muscle or neuropathologic features of ALS.

机构信息

Department of Translational Neuroscience, Barrow Neurological Institute, Phoenix, AZ, 85013, USA.

Rare and Orphan Disease Translational Center, The Jackson Laboratory, Bar Harbor, ME, USA.

出版信息

Biochem Biophys Res Commun. 2023 Feb 19;645:164-172. doi: 10.1016/j.bbrc.2023.01.032. Epub 2023 Jan 13.

Abstract

Matrin 3 is a nuclear matrix protein that has many roles in RNA processing including splicing and transport of mRNA. Many missense mutations in the Matrin 3 gene (MATR3) have been linked to familial forms of amyotrophic lateral sclerosis (ALS) and distal myopathy. However, the exact role of MATR3 mutations in ALS and myopathy pathogenesis is not understood. To demonstrate a role of MATR3 mutations in vivo, we generated a novel CRISPR/Cas9 mediated knock-in mouse model harboring the MATR3 P154S mutation expressed under the control of the endogenous promoter. The P154S variant of the MATR3 gene has been linked to familial forms of ALS. Heterozygous and homozygous MATR3 P154S knock-in mice did not develop progressive motor deficits compared to wild-type mice. In addition, ALS-like pathology did not develop in nervous or muscle tissue in either heterozygous or homozygous mice. Our results suggest that the MATR3 P154S variant is not sufficient to produce ALS-like pathology in vivo.

摘要

Matrin 3 是一种核基质蛋白,在 RNA 处理中具有许多功能,包括剪接和 mRNA 的运输。Matrin 3 基因 (MATR3) 中的许多错义突变与家族性肌萎缩侧索硬化症 (ALS) 和远端肌病有关。然而,MATR3 突变在 ALS 和肌病发病机制中的确切作用尚不清楚。为了证明 MATR3 突变在体内的作用,我们生成了一种新型的 CRISPR/Cas9 介导的基因敲入小鼠模型,该模型携带受内源性启动子控制表达的 MATR3 P154S 突变。MATR3 基因的 P154S 变体与家族性 ALS 有关。与野生型小鼠相比,杂合子和纯合子 MATR3 P154S 基因敲入小鼠并未出现进行性运动缺陷。此外,在杂合子或纯合子小鼠的神经或肌肉组织中均未出现类似 ALS 的病理学改变。我们的结果表明,MATR3 P154S 变体不足以在体内产生类似 ALS 的病理学改变。

相似文献

1
MATR3 P154S knock-in mice do not exhibit motor, muscle or neuropathologic features of ALS.
Biochem Biophys Res Commun. 2023 Feb 19;645:164-172. doi: 10.1016/j.bbrc.2023.01.032. Epub 2023 Jan 13.
2
MATR3 F115C knock-in mice do not exhibit motor defects or neuropathological features of ALS.
Biochem Biophys Res Commun. 2021 Sep 3;568:48-54. doi: 10.1016/j.bbrc.2021.06.052. Epub 2021 Jun 26.
4
Selective neuronal degeneration in MATR3 S85C knock-in mouse model of early-stage ALS.
Nat Commun. 2020 Oct 20;11(1):5304. doi: 10.1038/s41467-020-18949-w.
6
Analysis of spinal and muscle pathology in transgenic mice overexpressing wild-type and ALS-linked mutant MATR3.
Acta Neuropathol Commun. 2018 Dec 19;6(1):137. doi: 10.1186/s40478-018-0631-0.
7
A mutant MATR3 mouse model to explain multisystem proteinopathy.
J Pathol. 2019 Oct;249(2):182-192. doi: 10.1002/path.5289. Epub 2019 Jun 18.
9
Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis.
Neurobiol Aging. 2016 Jan;37:209.e17-209.e21. doi: 10.1016/j.neurobiolaging.2015.09.013. Epub 2015 Sep 28.
10
RNA-recognition motif in Matrin-3 mediates neurodegeneration through interaction with hnRNPM.
Acta Neuropathol Commun. 2020 Aug 18;8(1):138. doi: 10.1186/s40478-020-01021-5.

引用本文的文献

本文引用的文献

1
Molecular determinants and modifiers of Matrin-3 toxicity, condensate dynamics, and droplet morphology.
iScience. 2022 Feb 11;25(3):103900. doi: 10.1016/j.isci.2022.103900. eCollection 2022 Mar 18.
2
MATR3 F115C knock-in mice do not exhibit motor defects or neuropathological features of ALS.
Biochem Biophys Res Commun. 2021 Sep 3;568:48-54. doi: 10.1016/j.bbrc.2021.06.052. Epub 2021 Jun 26.
3
Selective neuronal degeneration in MATR3 S85C knock-in mouse model of early-stage ALS.
Nat Commun. 2020 Oct 20;11(1):5304. doi: 10.1038/s41467-020-18949-w.
4
Identification of a pathogenic intronic KIF5A mutation in an ALS-FTD kindred.
Neurology. 2020 Dec 1;95(22):1015-1018. doi: 10.1212/WNL.0000000000011064. Epub 2020 Oct 19.
5
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis.
N Engl J Med. 2020 Sep 3;383(10):919-930. doi: 10.1056/NEJMoa1916945.
6
Overview of current and emerging therapies for amytrophic lateral sclerosis.
Am J Manag Care. 2020 Aug;26(9 Suppl):S191-S197. doi: 10.37765/ajmc.2020.88483.
7
RNA-recognition motif in Matrin-3 mediates neurodegeneration through interaction with hnRNPM.
Acta Neuropathol Commun. 2020 Aug 18;8(1):138. doi: 10.1186/s40478-020-01021-5.
8
A robust TDP-43 knock-in mouse model of ALS.
Acta Neuropathol Commun. 2020 Jan 21;8(1):3. doi: 10.1186/s40478-020-0881-5.
9
ALS-linked TDP-43 knock-in mice exhibit splicing deregulation without neurodegeneration.
Mol Brain. 2020 Jan 20;13(1):8. doi: 10.1186/s13041-020-0550-4.
10
ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
Front Neurosci. 2019 Dec 6;13:1310. doi: 10.3389/fnins.2019.01310. eCollection 2019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验